Istradefylline

Back to search

Molecule Structure

Scientific Name

Istradefylline

Description of the Drug

Istradefylline is a selective adenoside A2A receptor antagonist indicated in adjunct to levodopa and carbidopa for the treatment of Parkinson’s Disease.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB11757

Brand Name(s)

Nourianz

Company Owner(s)

Kyowa Kirin Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Adenosine A2a receptor SINGLE PROTEIN ANTAGONIST CHEMBL251

Unichem Links

SureChEMBL SCHEMBL633262
WDI DR9711734
DrugBank DB11757
PubChem: Thomson Pharma 14878146
PubChem 5311037
Nikkaji J2.888.328E J1.018.438J
BindingDB 50176050
EPA CompTox Dashboard DTXSID7057652
DrugCentral 4882
Brenda 30038 39744
ChemicalBook CB11261287
Guide to Pharmacology 5608
GSRS e31753e1-0243-4cec-a47a-159eaa6d0633
rxnorm NOURIANZ ISTRADEFYLLINE
PubChem: Drugs of the Future 12014869
ChEBI 134726
ZINC ZINC000003803921